Barnesville Area Clinic in Barnesville, MN - Family Medicine

Barnesville Area Clinic is a primary clinic (Family Medicine) in Barnesville, Minnesota. The current practice location for Barnesville Area Clinic is 209 2nd St Se, Barnesville, Minnesota. For appointments, you can reach them via phone at (218) 354-2111. The mailing address for Barnesville Area Clinic is Po Box 279, Barnesville, Minnesota and phone number is (218) 354-2111.

Barnesville Area Clinic is licensed to practice in Minnesota (license number 25582) and its NPI number is 1487730404. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (218) 354-2111.

Contact Information

	Barnesville Area Clinic
	209 2nd St Se Barnesville MN 56514-0279
	(218) 354-2111
	(218) 354-2114

Primary Care Clinic Profile

Full Name	Barnesville Area Clinic
Speciality	Family Medicine
Location	209 2nd St Se, Barnesville, Minnesota
Authorized Official Name and Position	Owen R. Thompson (OWNER/PHYSICIAN)
Authorized Official Contact	2183542111
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Barnesville Area Clinic Po Box 279 Barnesville MN 56514-0279 Ph: (218) 354-2111	Barnesville Area Clinic 209 2nd St Se Barnesville MN 56514-0279 Ph: (218) 354-2111

NPI Details:

NPI Number	1487730404
Provider Enumeration Date	10/31/2006
Last Update Date	06/16/2008

Medical Identifiers

Medical identifiers for Barnesville Area Clinic such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1487730404	NPI	-	NPPES
40936TH	Other		MNBS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	25582 (Minnesota)	Primary

News Archive

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

FibroGen, today announced interim results of a phase 1/2 trial of FG-3019, a therapeutic antibody against connective tissue growth factor, in combination with gemcitabine and erlotinib in individuals with unresectable pancreatic cancer.

Newly identified protein markers have potential to contribute to better understanding of heart disease

Researchers at the Intermountain Medical Center Heart Institute in Murray, Utah, have discovered that elevated levels of two recently identified proteins in the body are inflammatory markers and indicators of the presence of cardiovascular disease.

Study examines ways to reduce growing cancer burden in developing world

"The growing burden of cancer in developing countries could be reduced without expensive drugs and equipment, scientists said on Monday, but it requires a global effort similar to the fight against HIV/AIDS," Reuters reports in an article that examines a study published in the Lancet by a group of American scientists who have created the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries.

Research provides insight into neurobiology of aggression and bullying

Duke-NUS researchers have discovered that a growth factor protein, called brain-derived neurotrophic factor, and its receptor, tropomyosin receptor kinase B affects social dominance in mice. The research has implications for understanding the neurobiology of aggression and bullying.

Researchers link protein clusterin to many facets of cardiometabolic syndrome risk

During a study spanning nearly a decade, researchers at The Ohio State University College of Medicine, Houston Methodist Research Institute and Houston Methodist Cancer Center have linked the protein clusterin - for the first time - to many different facets of cardiometabolic syndrome risk through its actions in the liver.

Barnesville Area Clinic - Primary Care in Barnesville, MN